Healthcare Financial News

India faces a significant burden from increasing cases of orthopedic disorders due to an aging population, rising obesity rates, and high incidences of road accidents. This combination significantly elevates the demand for orthopedic devices, with joint replacements being particularly in demand. Against this backdrop, India’s orthopedic devices market is set to grow at a compound annual growth rate (CAGR) of around 5% through 2033, forecasts GlobalData, a data and analytics company.

OneSource, a TPG Growth-backed specialty pharma contract development and manufacturing organisation (CDMO), are in discussions with a clutch of investors including White Oak Capital, Swiss fund HBM Healthcare Investments, Tybourne Capital and 360 ONE, to raise about $200 million (₹1,670 crore), said sources. OneSource (formerly Stelis Biopharma), promoted by Strides Pharma and its promoter Arun Kumar, got demerged from Strides Pharma, and renamed as OneSource last year. The company will now seek final approval from the NCLT for the demerger, and listing approvals from BSE and NSE. The company expects listing in the next 12 months. In September 2023, the board of directors of Steriscience Specialties, Strides and OneSource Specialty Pharma (formerly Stelis Biopharma) proposed to combine the CDMO business of Strides and Steriscience under OneSource.

Avtar & Seramount BCWI – MICI Study has revealed. Findings from the 9th edition of ‘Best companies for women in India (BCWI)’ listing announced by workplace culture consulting company Avtar show that average women representation across industries today is at 36.6% and close to 40% at entry level. Sectors like professional services are close to gender balance with 46% women while manufacturing reported a gender ratio of 20%, an indication of intensifying efforts. GCCs report the lowest attrition rate of women at 10%, the report found while FMCG is the best at retaining women in leadership with the attrition rate of women at 2.6% vis-à-vis men’s attrition rate at 7%.

Income Tax Department has alleged a tax evasion of about₹2,500 crore by Hinduja Global Solutions' (HGS). An internal report, submitted earlier this month based on a probe carried over the past nine months, has charged HGS with the evasion. Invoking the General Anti-Avoidance Rule, tax authorities have charged the company merging with a loss-making entity subsequent to divesting its healthcare business at a gain with the purpose of avoiding tax.

Meghalaya is only the third state in India in area of both health and agriculture, after Uttar Pradesh & Bihar, with whom the Gates Foundation is establishing a partnership. The MoU was signed in the presence of the Chief Minister Conrad K Sangma and Minister of Health & Family Welfare and Agriculture, M Ampareen Lyngdoh. M. Hari Menon Director of the India Country Office at the Gates Foundation, and Sampath Kumar, Principal Secretar Health & Family Welfare Department on behalf of the state signed the MoU.

JHS Svendgaard Laboratories Ltd.(up 4.99%), Parag Milk Foods Ltd.(up 2.38%), Nakoda Group Of Industries Ltd.(up 2.33%), Hatsun Agro Products Ltd.(up 0.40%), Marico Ltd.(up 0.38%), LT Foods Ltd.(up 0.21%), Heritage Foods Ltd.(up 0.06%), Procter & Gamble Hygiene & Healthcare Ltd.(up 0.04%), Colgate-Palmolive(India)Ltd.(up 0.02%) and Tata Consumer Products Ltd.(up 0.01%) stood among the top gainers.

The fundraising will include a primary £20m level with a £10m overallotment facility, making the total offer of up to £30m. New investors will have the option to split their investment 60/40 between Octopus AIM VCT and Octopus AIM VCT 2, or put 100% of their investments in either of the two vehicles. Octopus Investments reshuffles senior leadership team in business restructure Octopus AIM VCT and Octopus AIM VCT 2 were launched in 1997 and 2005, respectively, and target companies with growth potential across various sectors including technology, healthcare and the environment. F...

Max Healthcare Institute Ltd. rose 4.32 per cent to Rs 1099.65 in Tuesday's trade. It hit an intraday high of Rs 1117.05 and low of Rs 1066.85, respectively, during the day. The stock quoted a 52-week high price of Rs 1117.05 and low of Rs 531.05.

Modi's three-day visit to the United States, where he engaged with leaders from US-based companies specializing in cutting-edge technologies, including AI, quantum computing, and semiconductors. Both Pichai and Huang praised Modi's vision for a "Digital India" and his focus on AI's potential to transform various sectors, such as healthcare, education, and agriculture.Speaking after the meeting, Pichai highlighted Modi's commitment to harnessing AI for societal benefits in India.

retail participation, favourable market conditions, and diverse investment strategies. Equity funds, in particular, have seen significant inflows.

Max Healthcare Institute Ltd. dropped 2.65 per cent to Rs 1040.0 at 02:10PM (IST) in Monday's trade. The scrip hit a high of Rs 1065.6 and low of Rs 1028.05 so far during the session. The stock had closed at Rs 1068.4 in the previous session. The counter had a total traded volume of 02:10PM shares so far with a turnover of Rs 7.68 crore on BSE. The stock traded at a price-to-earnings multiple of 95.78 and a price-to-book ratio of 9.48.

Subscribe to enjoy similar stories. A major market correction is unlikely unless an unforeseen global event occurs beyond anyone’s control, according to Anuj Kapoor, MD & CEO of Private Wealth and Alternatives at JM Financial. “If investors wait for a correction beyond 5-10%, they might be left waiting for a long time," he said.

Subscribe to enjoy similar stories. Brands that embraced influencers for their reach, authenticity and affordability are recalibrating strategies, as they target maximum bang for their marketing buck. For several consumer brands that swept over YouTube and Instagram thanks to the wide reach of influencers, returns on investment (ROI) are beginning to nag.

Subscribe to enjoy similar stories. MUMBAI : If your current job is still in the work-from-home (WFH) mode, you may like to explore Dubai's virtual work visa, which offers anyone working remotely residency for a year. You can explore various sights and scenery—man-made beaches, Burj Khalifa, local food and people—while enjoying a long workcation in the United Arab Emirates (UAE) city.

Scientific American has only twice received presidential endorsements. After receiving a presidential endorsement, a prestigious science magazine, only the second in its 179-year history, has entered the political arena. On Monday, Scientific American announced its official endorsement of Democratic presidential candidate Kamala Harris with the headline, ‘Vote for Kamala Harris to Support Science, Health, and the Environment.’ After supporting President Joe Biden in the 2020 election, Harris is Scientific American's second-ever presidential endorsement in the publication's history. The editors pushed a candidate who offers the country better prospects, relying on science, solid evidence, and the willingness to learn from experience, writing that the US faces two futures. In the other future, the new president puts public health and safety in jeopardy and rejects evidence, preferring instead absurd conspiracy theories. Also Read: Is US Secret Service probing Elon Musk over Donald Trump assassination attempt tweet?

«We clearly believe that at this point of time, if you look at risk reward, largecap is where risk reward looks far better compared to midcaps and smallcaps,» says Harshad Patwardhan, CIO, Union MF. We were speaking with our technical expert earlier and he is talking about 26,000 on the index as soon as next week. What about the top of the year because at 24,000 we thought that perhaps fundamentals are not running as fast as the valuations, 25,000 same questions being asked about valuations, but it just seems like it is all about liquidity, momentum, and flows. Harshad Patwardhan: Absolutely right, fundamentals do assert themselves over medium to long term. But in the near term, clearly the liquidity or the demand-supply tends to overwhelm fundamentals. However, I must point out that medium- to long-term fundamentals of Indian economy, corporate sector look very-very robust. So, to that extent, yes, sometimes the valuations will run ahead of themselves. Stocks and sectors will run ahead of themselves but so long as the medium- to long-term trajectory you are sure of, these things tend to happen. So, I do not really worry too much about it. Having said that, we clearly believe that at this point of time, if you look at risk reward, largecap is where risk reward looks far better compared to midcaps and smallcaps.

West Bengal government on Thursday issued a list of directives on the safety, security and efficient functioning of healthcare professionals, saying those orders need to be implemented immediately. The directives came a day after the government held a meeting with agitating junior doctors over the same issues. In a two-page communication, Chief Secretary Manoj Pant to Principal Secretary (health) NS Nigam, the directions mentioned the need for «adequate availability of on-duty rooms, washrooms, CCTVs, drinking water facilities in the healthcare facilities.» Works in this connection must be completed as early as possible, it mentioned in one of the 10 directives issued.

Subscribe to enjoy similar stories. Singapore's Temasek Holdings is close to buying Peak XV's 18-20% stake in Bengaluru-based Cloudnine Hospitals for around $125 million, three people aware of the development said. The deal, which has been in the works for more than a year and a half, may value the specialist mother and baby care hospitalat around $600 million, the people cited above said on the condition of anonymity.

hospital chain Aster DM Healthcare and Hyderabad-based Quality CARE India is in its final stages of negotiations, and the deal is expected to be signed by the end of this month, investment banking sources told ET. The likely swap ratio in the new merged entity is expected to be 55% for Aster DM and 45% for Quality CARE. The merger will proceed through a share swap via a scheme of amalgamation approved by the National Company Law Tribunal (NCLT) but without triggering an open offer, said the bankers.

This fixed-benefit healthcare policy or plan covers specific ailments and pays a lump sum amount to the policyholder. The policyholder can use the payout to pay for his/her medical expenses and non-medical expenditures, such as children’s fees, day-to-day living expenses, etc. So, does a critical illness cover offer coverage for all forms of cancer? Will the person receive the payout as soon as you make a claim? Here are some common misconceptions about critical illness insurance and some clarifying facts..

Subscribe to enjoy similar stories. Emami Ltd is gearing up for a better FY25, eyeing double-digit domestic revenue growth after clocking a 4% increase in FY24. So, what’s the game plan? More focus on direct-to-consumer (D2C).